+ Based on the confirmation of the blood sugar lowering efficacy of the recombinant human insulin analogue Gluculin
    which is developed as a new diabetes treatment, the second pre-clinical experiment on anti-diabetic efficacy of Gluculin will be
    additionally conducted from October 12, 2020.

+ In addition, the first pre-clinical trial to confirm the anti-diabetic efficacy of Glucumin, which was developed as an oral medicines
    for the dropping blood sugar, is also conducted.

+ We ask for your interest and support to complete the successful pre-clinical experiment and secure the results.